Third Quarter Revenue of $529.6 Million, up 12.2% year-over-year Q3 Diluted EPS (GAAP) of $0.36, up 10.7% from $0.33 in Q3 of 2024 Q3 Adjusted Diluted EPS (Non-GAAP) (1) of $0.48, up 10.8% from ...

Hilton’s third quarter was marked by strong revenue and profit figures that exceeded Wall Street expectations, prompting a ...

Churchill Downs delivered a positive third quarter, with results above Wall Street’s expectations and the stock rising ...

UPM is a large producer and consumer of electricity in Finland and separately hedges part of its electricity sales and purchases. Based on UPM’s estimated unhedged net electricity sales position in ...

Outokumpu Corporation Interim report October 29, 2025 at 9.00 am EET Outokumpu interim report January-September 2025 - Adjusted EBITDA was EUR 34 million in Q3, reflecting weakness in the European mar ...

Palantir Q3 2025 earnings preview. Analyst expectations, key metrics, valuation concerns and technical analysis ahead of 3 ...

WD-40’s third quarter results were met with a positive market reaction, reflecting the company's ability to deliver growth ...

Medpace’s third quarter results were well received by the market, driven by broad-based revenue growth and robust net new ...

Tenet Healthcare Corporation ( NYSE: THC) Q3 2025 Earnings Call October 28, 2025 10:30 AM EDT Good morning, welcome to Tenet Healthcare's Third Quarter 2025 Earnings Conference Call. [Operator ...

Q3 2025 Earnings Call October 28, 2025 5:00 PM EDTCompany ParticipantsMike BishopScott Bibaud - President, CEO ...

Ongoing investments in new tech, marketing and sales teams dragged down the company’s net income in Q3, though YoY revenue ...

Research and Development Expenses -- $9.6 million in the third quarter of 2025, down from $12.3 million in Q3 2024, due to ...